Anhui Anke Biotechnology (Group) Co., Ltd. Stock: price and insider trades · China
安科生物
No insider purchase over the last 90 days. The latest, by 周源源, was filed 30 May 2023.
Anhui Anke Biotechnology (Group) Co., Ltd.: what insiders have been doing
Anhui Anke Biotechnology (Group) Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). No insider at Anhui Anke Biotechnology (Group) Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 30 May 2023.
The full history, which starts in 2021, counts 2 purchases against 1 sale.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -7.1%Entry CN¥10.06 · Close at T+365 CN¥9.35
- -44.7%Entry CN¥16.54 · Close at T+365 CN¥9.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 284,300 shares100.0% of flowA股XSHESZSE:173000006628138880Canonical exit: 28 Aug 2023 (T+90)
- 200,000 shares100.0% of flowA股XSHESZSE:173000005085677950
- 100 shares100.0% of flowA股XSHESZSE:173000005072993760Canonical exit: 1 Sept 2021 (T+90)
3 of 3 declarations
About Anhui Anke Biotechnology (Group) Co., Ltd.
安科生物 is a company focused on the healthcare and pharmaceutical sector, specializing in the development of biopharmaceutical products. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
